aic-100
affyimmune therapeutics
['affyimmune']
news from #asco23: s #cart agent, aic100, has shown promise for thyroid cancers, with encouraging safety and efficacy in data from a phase 1 clinical trial. 
Associate editorial director, @Neurology_Live 🧠 and @CGT_Live 🧬 Host of the #MindMoments podcast 🎧 and @medicalwrldnews Deep Dive 📺